The purpose of this study is to evaluate the efficacy of BHV3000 compared to placebo for
subjects with treatment refractory Trigeminal Neuralgia as measured by a 2-point or greater
reduction in the average Numeric Pain Rating Scale between the two-week treatment phases.
If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.
Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.